Sonnet BioTherapeutics Holdings, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Sonnet BioTherapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 5.04M shares, a 277% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.04M shares, a 426% increase from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 197K shares, a 88.7% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 1.04M +841K +426% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-14
2022 197K -1.56M -88.7% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-14
2021 1.75M Oct 1, 2020 Sep 30, 2021 10-K 2022-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.